Retour

Choisissez votre région

Corporate

Demandez un entretien de conseil sur les cellules souches

En savoir plus

Liste des patients
traités

Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:

Image
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Nr. Source Type de source Diagnostic Domaine médical Année d’application Thérapie Pays Âge du bénéficiaire
6401 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 63
6402 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 56
6403 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 71
6404 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 51
6405 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 67
6406 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 67
6407 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 49
6408 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 60
6409 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Poland 54
6410 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Germany 71
6411 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2018 Standard Therapy Germany 71
6412 Apheresis Allogeneic Fanconi Anemia Hematology 2018 Standard Therapy Poland 9
6413 Apheresis Allogeneic Follicular Lymphoma Hematology 2018 Standard Therapy Poland 44
6414 Apheresis Autologous Follicular Lymphoma Hematology 2018 Standard Therapy Germany 65
6415 Apheresis Allogeneic Follicular Lymphoma (Non-Hodgkin Lymphoma) Hematology 2018 Standard Therapy Poland 56
6416 Apheresis Autologous Germ Cell Tumor Hematology 2018 Standard Therapy Germany 23
6417 Apheresis Autologous Germ Cell Tumor Hematology 2018 Standard Therapy Germany 31
6418 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 38
6419 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 27
6420 Apheresis Allogeneic Hypoplastic Mds-Eb2 With Incipient Saml Hematology 2018 Standard Therapy Poland 63
6421 Apheresis Autologous Large B-Cell Non-Hodgkin-Lymphoma Hematology 2018 Standard Therapy Germany 66
6422 Apheresis Allogeneic Leukemia Hematology 2018 Standard Therapy Poland 34
6423 Apheresis Allogeneic Lymphomatoid Granulomatosis Hematology 2018 Standard Therapy Germany 36
6424 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 66
6425 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 64
6426 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 44
6427 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 66
6428 Apheresis Autologous Morbus Hodgkin Hematology 2018 Standard Therapy Germany 65
6429 Apheresis Autologous Morbus Hodgkin Hematology 2018 Standard Therapy Germany 31
6430 Apheresis Allogeneic Morbus Hodgkin-Relapse Hematology 2018 Standard Therapy Germany 35
6431 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
6432 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
6433 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
6434 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
6435 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 57
6436 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 53
6437 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 57
6438 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6439 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 47
6440 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
6441 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
6442 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6443 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
6444 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6445 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 54
6446 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 58
6447 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 51
6448 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
6449 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 52
6450 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6451 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6452 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6453 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6454 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6455 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 63
6456 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 55
6457 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
6458 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
6459 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6460 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6461 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 55
6462 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6463 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6464 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 52
6465 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
6466 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
6467 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 73
6468 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 42
6469 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
6470 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6471 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
6472 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
6473 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6474 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 51
6475 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
6476 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 50
6477 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
6478 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 50
6479 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6480 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 56
6481 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 74
6482 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6483 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 72
6484 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
6485 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 50
6486 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 62
6487 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 68
6488 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 54
6489 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6490 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 22
6491 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 64
6492 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 77
6493 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 66
6494 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 60
6495 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 68
6496 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 39
6497 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 62
6498 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 56
6499 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6500 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63